{"name":"Rain Oncology Inc","slug":"rain-oncology-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":61400000,"netIncome":-75724000,"cash":61955000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"Nature","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - Nature","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxQc1dNM1d3eGNJbllFZTFvMjlidmlxM3lYak9fbmtpUG5LcWFpT0IzWWl6SXgySkRtLUt3LU8xQWtGM2RKNTUxQUNldUUyeDl5T0dLRFo1SHJMcmNhNklTemRja0FDOENQTG1QcjJLY0VTLXZTek1LUjBKR2xyNU9Td1I4TjFpaEZCY1lIUldyYS0xVl9mbFpxdlp6VmdiQTM1eGdnaTc4cVU0QWRuTnYybWUwWU50UkhPZmlmQm5McXp0TDNOYTRkelFyZkRNWmRGc3k2MkNJOVk4czJhd2JpNTFjMi1CMEgxQy1fRWNOZTE4by1pYzJmX0pPWUpTMXhBVVhtQk9rMExGQ0hvTXJfbFNVQ1BDWUM2S1Q4Tml6VXpnM0gxdDZiT0diV3EwSDMyYkpHUHFaa3YzQQ?oc=5","date":"2025-12-10","type":"pipeline","source":"PR Newswire","summary":"Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight - PR Newswire","headline":"Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Tr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNdW5ER3FDTDc1cnp1YWlQTG1mREZXOUhiemJyNFluRG1hNVphZEtzVnBQLXJDM2xtX1E4elJxZXd0WHMxSDFOdXhxaV9kM2NmUzZLOTJTZzJnT3ZsdkZOQ2Z5UWh3bkQzSkQ0dTFvV0ppUlhPWTNfX2RscHdhMzNCZjc3Qkp0VUFwRUZ3alJfY0RNdFlFU2M5LTE0RS1hdHV3dWVCVw?oc=5","date":"2025-10-22","type":"pipeline","source":"Bloomberg Law News","summary":"Rain Oncology Settles Suit Over 88% Stock Drop for $7.3 Million - Bloomberg Law News","headline":"Rain Oncology Settles Suit Over 88% Stock Drop for $7.3 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxONGZxekJhQnh2MWh1OXVqekp3WjZUTnlycXZjM2NCVlJjZ2NOVVh4elFZNkRJMTZpY21vQ1BKWDF2X2djLW5wRV9mOHVJeUhlVXdFS2VGVEZPT0FITnc2OGNraDNMYXJGTzI3TlplU1VJMm1ZZkdOVXNTd2NuRm9hRjBYR0RPZUpSaDVkLXpOOUM3UTV1WWlVbmluRUxZaUlv?oc=5","date":"2025-05-16","type":"pipeline","source":"The Pharma Letter","summary":"Pathos’ $365 million Series D shows faith in AI-driven drug discovery - The Pharma Letter","headline":"Pathos’ $365 million Series D shows faith in AI-driven drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQT1FFclRHMkNsMldCRjlGbVYwdGdJcW9wZVBIeVpUUnFHbzZ6WE5xZnFJTVZrdlRqMzRNNzY3aXRzcVZCSTRZS3dvYnNvMVFXOFBQRzhaWmRrVnROczJZamVOZnNCT01UQi1pamF1Q19RS3Q0cUdsamxQT1E1ZFpIeDRVQTU0QnFDcEgyc1N6enh3d3BRelNGbnpaRHhTUm43Mlp0MEl1RkdtRVA4MzF3?oc=5","date":"2025-05-15","type":"trial","source":"Fierce Biotech","summary":"Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug - Fierce Biotech","headline":"Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNZmtDSmxyMWl0SDhCeGFyUzhQNFduUUgzaEc1N1FQaGkybVFXTUlUVjFVUEkyV2JGLXNUMUlQNWwxZVB5UFdKTlFTTXRvcXpUU1VZVnFJZ0I5Y3VZbU44aXVOTE12UjltckQwUmtHU0d6YXBKSnJYZmdQUmJzSHQxTHZwRWpDMGJqMlhlRUZRRzIydGdGUGUyOVZ2eGRza2dpUElsYmZTTQ?oc=5","date":"2025-02-25","type":"pipeline","source":"Bloomberg Law News","summary":"Rain Oncology Investors Advance Securities Suit Via Narrow Path - Bloomberg Law News","headline":"Rain Oncology Investors Advance Securities Suit Via Narrow Path","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBLTTJSUmZLTTRHUC1uSGw4RjVtcFZTdEdWejlpV0Fqb0lVOW1NQ0lxbUNieGpqTWZXX0NBRElJaGkwbVMtUkE2bmQ0d1JucHJK?oc=5","date":"2025-02-15","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQYUVROXVNazhHMWpMOEpsb1hhdVIzenVod2poTUZBckkzU291Mk92TjV1VXlxanNRbkcwdEtQZWdQc0xqci13dE1qeEo4N3B0OWNYUVhRcTJGcUtkZkFuNnhfQW9iR1VEZS14NG1BNjFnV01kUzlaaTVxaFduanMyWEI5V3pNTTdHeTVLSEFhSDdZUkpKQWU4?oc=5","date":"2024-01-29","type":"pipeline","source":"BioPharma APAC","summary":"Pathos AI Completes Acquisition of Rain Oncology - BioPharma APAC","headline":"Pathos AI Completes Acquisition of Rain Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOdThwelJGWk9QQ19fbUxPTTA1dGhFaGFwMG5aZ096Mk1LNnVQUzhSaUxGTk1QVF9EZGhBY1B5QUdDbkpTU1VzVmFpTEVfWW1nTWN2MFFmYVBjTFRBMzBhNGw2eWRwdE83SzgwQ0ZtdXVHTzdLU3cxd1B5ZkZuMzliS1MzanFDNzVwQkpGaUM1S3Rjb2hQNTg1Nnl1aU9yWXp3Z3JZcmNxeHI3QTFCcU8zUA?oc=5","date":"2023-12-14","type":"deal","source":"Fierce Biotech","summary":"Rain ends stormy year of layoffs by opting to be acquired by Pathos AI over Concentra - Fierce Biotech","headline":"Rain ends stormy year of layoffs by opting to be acquired by Pathos AI over Concentra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcGxsdGhpUkdvUWE5MW0tS3l1WjJmM2pLbnRlNVdxSnhXUDh0VnlBbXVRaGRWTUJzSk55eTJqWVBTRHlubThTQm00ZlZQMWxFU0UzMTNsZ1JWdXBCa0haYmtYZm9uSEpjYmdseFEwbzk5NE9oX3BQb3J3RnBKdjkwa2ZhMTJTNXRDM0pz?oc=5","date":"2023-10-16","type":"pipeline","source":"BioPharma Dive","summary":"Concentra makes bid for struggling biotech Rain - BioPharma Dive","headline":"Concentra makes bid for struggling biotech Rain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOSWhlck0xNTRWS2NWLUY2QXp6UEJRWEpZVjJPQ3RIZ0NiWFlyRDRJZXBWUjFDeUMtZEJKN2ozVmZBdGJzTHVvbWU3dDhVS25kc0RIOTlKM2NDZlhCbmxEYVU0ZzZKWmtmYUxPX0dVbTlJTE1JVHVaSG9QSDJUTlF4cEFxUVFpR29DY2ZCSnJzZnZGZERuWkpTX3VNNlJhdTA?oc=5","date":"2023-05-30","type":"trial","source":"BioPharma Dive","summary":"Rain Oncology to cut workforce by 65% after study failure - BioPharma Dive","headline":"Rain Oncology to cut workforce by 65% after study failure","sentiment":"negative"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":61400000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-75724000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":61955000,"cashHistory":[],"totalAssets":135180000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}